Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, ...

At CPHI Europe, an expert discussed the promise of gummies as a drug delivery system and their unique manufacturing ...

Arda Therapeutics has secured $43m in Series A financing led by Andreessen Horowitz to develop targeted cell depletion ...

Patient recruitment is a critical yet challenging phase in clinical trials. EMIS has been lauded for its significant ...

Boehringer Ingelheim and Circle Pharma have signed a partnership and licence agreement focused on developing a new cancer ...

The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.

The deal allows MSD to license one or more therapies against inflammatory diseases developed using the UK biotech’s ...

Emergent said it is separately working on increasing the availability of its overdose reverser on site for businesses.

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

City Therapeutics has announced its launch accompanied by a $135m Series A financing to lead advancements in RNAi-based ...

As a major report highlights the challenges of a struggling NHS, the call for preventative care is growing in the UK.

Ipsen has received the UK MHRA's approval for its Elafibranor (Iqirvo) for the treatment of primary biliary cholangitis (PBC) ...